recall
Alert: Norbrook Laboratories Enroflox 100 Injection (enrofloxacin)
Product sterility cannot be assured.
recall
Alert: Norbrook Laboratories Noromectin Injection (ivermectin)
Product sterility cannot be assured.
recall
Alert: Norbrook Laboratories Ivermax 1% Injection (ivermectin)
Product sterility cannot be assured.
recall
Alert: American Health Packaging Valsartan Tablets, USP, 160 mg
Presence of probable human carcinogen N-Nitrosodiethylamine
recall
Alert: Torrent Pharmaceuticals Losartan Potassium Tablets, USP and Losartan Potassium /Hydrochlorothiazide Tablets, USP (Expanded Recall)
Presence of N-Methylnitrosobutyric acid
recall
Alert: Aurobindo Pharma/ScieGen Pharmaceuticals Irbesartan
Presence of probable carcinogen N-nitrosodiethylamine
recall
Alert: Camber Pharmaceuticals Losartan Potassium Tablets, USP, 25 mg, 50 mg and 100 mg
Presence of potential carcinogen N-Nitroso N-Methyl 4-amino butyric acid
recall
Alert: AurobindoPharma Amlodipine Valsartan Tablets USP and Valsartan Tablets, USP (Expanded Recall)
Due to presence of probable carcinogen N-nitrosodiethylamine
recall
Alert: AurobindoPharma Acetris Valsartan Tablets, USP
Due to presence of probable carcinogen N-nitrosodiethylamine
recall
Alert: Macleods Pharmaceuticals Losartan Potassium/Hydrochlorothiazide Combination Tablets 100mg/25mg
Presence of probable carcinogen N-nitrosodiethylamine
recall
Alert: Edwards Lifesciences Swan-Ganz Thermodilution Catheter
Incorrect assembly causing reversal of lumens
recall
Alert: Smiths Medical sterile saline and sterile water products for inhalation
Potential exposure to infectious agents (bacillus infantis and staphylococcus epidermidis)
recall
Alert: Hare Today Gone Tomorrow Ground Chicken
Presence of Salmonella and Listeria monocytogenes
recall
Alert: Losartan Potassium Tablets, USP and Losartan Potassium and Hydrochlorothiazide Tablets, USP (Expanded Recall)
Presence of probable carcinogen N-nitrosodiethylamine
recall
Alert: Irbesartan and Irbesartan HCTZ Tablets
Presence of probable carcinogen N-nitrosodiethylamine
recall
Alert: Ceftriaxone for Injection USP, 250mg, 500mg, 1g and 2g
Presence of visual grey particulate matter in reconstituted vials
recall
Alert: Losartan Potassium Tablets, USP (Expanded Recall)
Presence of probable carcinogen N-nitrosodiethylamine
